Annual EBIT
-$4.61 M
-$2.02 M-78.05%
December 1, 2023
Summary
- As of February 7, 2025, LIPO annual earnings before interest & taxes is -$4.61 million, with the most recent change of -$2.02 million (-78.05%) on December 1, 2023.
- During the last 3 years, LIPO annual EBIT has fallen by -$4.55 million (-8481.19%).
- LIPO annual EBIT is now -8481.19% below its all-time high of -$53.70 thousand, reached on December 1, 2020.
Performance
LIPO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.44 M
-$506.50 K-53.99%
September 1, 2024
Summary
- As of February 7, 2025, LIPO quarterly earnings before interest & taxes is -$1.44 million, with the most recent change of -$506.50 thousand (-53.99%) on September 1, 2024.
- Over the past year, LIPO quarterly EBIT has dropped by -$506.50 thousand (-53.99%).
- LIPO quarterly EBIT is now -325.01% below its all-time high of -$339.90 thousand, reached on June 1, 2021.
Performance
LIPO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$4.26 M
-$121.00 K-2.92%
September 1, 2024
Summary
- As of February 7, 2025, LIPO TTM earnings before interest & taxes is -$4.26 million, with the most recent change of -$121.00 thousand (-2.92%) on September 1, 2024.
- Over the past year, LIPO TTM EBIT has dropped by -$121.00 thousand (-2.92%).
- LIPO TTM EBIT is now -595.61% below its all-time high of -$612.90 thousand, reached on March 1, 2021.
Performance
LIPO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LIPO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -78.0% | -54.0% | -2.9% |
| 3 y3 years | -8481.2% | -54.0% | -2.9% |
| 5 y5 years | -8481.2% | -54.0% | -2.9% |
LIPO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -147.9% | at low | -302.2% | +5.8% | -129.4% | +10.0% |
| 5 y | 5-year | -8481.2% | at low | -325.0% | +5.8% | -595.6% | +10.0% |
| alltime | all time | -8481.2% | at low | -325.0% | +5.8% | -595.6% | +10.0% |
Lipella Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.44 M(+54.0%) | -$4.26 M(+2.9%) |
| Jun 2024 | - | -$938.10 K(-21.3%) | -$4.14 M(-12.6%) |
| Mar 2024 | - | -$1.19 M(+73.0%) | -$4.74 M(+2.8%) |
| Dec 2023 | -$4.61 M(+78.0%) | -$688.90 K(-48.0%) | -$4.61 M(+7.7%) |
| Sep 2023 | - | -$1.32 M(-13.7%) | -$4.28 M(+16.7%) |
| Jun 2023 | - | -$1.53 M(+44.3%) | -$3.67 M(+25.8%) |
| Mar 2023 | - | -$1.06 M(+195.8%) | -$2.91 M(+12.6%) |
| Dec 2022 | -$2.59 M | -$359.20 K(-49.6%) | -$2.59 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$712.10 K(-8.8%) | -$2.61 M(+7.8%) |
| Jun 2022 | - | -$780.40 K(+6.0%) | -$2.42 M(+22.2%) |
| Mar 2022 | - | -$736.30 K(+92.2%) | -$1.98 M(+6.6%) |
| Dec 2021 | -$1.86 M(+3361.1%) | - | - |
| Dec 2021 | - | -$383.00 K(-26.8%) | -$1.86 M(+26.0%) |
| Sep 2021 | - | -$522.90 K(+53.8%) | -$1.48 M(+54.9%) |
| Jun 2021 | - | -$339.90 K(-44.5%) | -$952.80 K(+55.5%) |
| Mar 2021 | - | -$612.90 K | -$612.90 K |
| Dec 2020 | -$53.70 K | - | - |
FAQ
- What is Lipella Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals annual EBIT year-on-year change?
- What is Lipella Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals quarterly EBIT year-on-year change?
- What is Lipella Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals TTM EBIT year-on-year change?
What is Lipella Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of LIPO is -$4.61 M
What is the all time high annual EBIT for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high annual earnings before interest & taxes is -$53.70 K
What is Lipella Pharmaceuticals annual EBIT year-on-year change?
Over the past year, LIPO annual earnings before interest & taxes has changed by -$2.02 M (-78.05%)
What is Lipella Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of LIPO is -$1.44 M
What is the all time high quarterly EBIT for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$339.90 K
What is Lipella Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, LIPO quarterly earnings before interest & taxes has changed by -$506.50 K (-53.99%)
What is Lipella Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of LIPO is -$4.26 M
What is the all time high TTM EBIT for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high TTM earnings before interest & taxes is -$612.90 K
What is Lipella Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, LIPO TTM earnings before interest & taxes has changed by -$121.00 K (-2.92%)